IL6 and pulmonary arterial hypertension: Although IL-6 has not been extensively researched in children, a study of pediatric PAH incorporating a broad cytokine panel and univariate analysis found that IL-6 was linked to unfavorable outcomes, indicating that IL-6 may have some use as a prognostic marker in pediatric patients [13].